Covered recipient · General Payments record
KRISTIAN H WALL
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,423.53
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $285.91 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $200.00 | 12 |
| Takeda Pharmaceuticals U.S.A., Inc. | $48.85 | 3 |
| PFIZER INC. | $37.06 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.07 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300209 | CMS |
| ABBVIE INC. | $14.57 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300211 | CMS |
| ABBVIE INC. | $15.63 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300213 | CMS |
| ABBVIE INC. | $11.72 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300215 | CMS |
| ABBVIE INC. | $22.93 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300217 | CMS |
| ABBVIE INC. | $19.15 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300219 | CMS |
| ABBVIE INC. | $18.58 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300221 | CMS |
| ABBVIE INC. | $14.68 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300223 | CMS |
| ABBVIE INC. | $26.07 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300225 | CMS |
| ABBVIE INC. | $16.08 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300227 | CMS |
| ABBVIE INC. | $6.43 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300229 | CMS |
| ABBVIE INC. | $19.09 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106300231 | CMS |
| PFIZER INC. | $17.80 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130912702 | CMS |
| PFIZER INC. | $19.26 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130984709 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.97 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137694092 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.59 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137694094 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.29 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137694096 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.